SCHEMBL24026271

SCHEMBL24026271

COc1ccc2c3c4c5ccccc5n(-c5ccccc5)c4ccc3n(-c3ccccn3)c2c1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 6/20 0.42
HTT P42858 3/20 0.41
MAPT P10636 2/20 0.41
ALDH1A1 P00352 4/20 0.41
HPGD P15428 4/20 0.41
MAPK1 P28482 1/20 0.41
MAPK10 P53779 1/20 0.41
NCOA1 Q15788 1/20 0.41
NCOA3 Q9Y6Q9 1/20 0.41
FGFR1 P11362 1/20 0.41
EDNRA P25101 1/20 0.40
PDE10A Q9Y233 2/20 0.40
L3MBTL1 Q9Y468 2/20 0.39
MEN1 O00255 2/20 0.39
KMT2A Q03164 2/20 0.39
HSD17B10 Q99714 1/20 0.39
POLB P06746 1/20 0.38
ATM Q13315 1/20 0.38
CYP19A1 P11511 1/20 0.38
MAPK8 P45983 3/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24026164 0.91 KDM4E (0.39) KDM4EHTTMAPTALDH1A1HPGD
SCHEMBL24026226 0.91 KDM4E (0.44) KDM4EHTTMAPTALDH1A1HPGD
SCHEMBL24026208 0.90 KDM4E (0.43) KDM4EHTTMAPTALDH1A1HPGD
SCHEMBL15063446 0.87 KDM4E (0.48) KDM4EHTTMAPTALDH1A1HPGD
SCHEMBL10027615 0.85 KDM4E (0.52) KDM4EHTTALDH1A1MAPK1L3MBTL1
SCHEMBL17989831 0.83 KDM4E (0.41) KDM4EHTTALDH1A1HPGDL3MBTL1
SCHEMBL17248316 0.83 KDM4E (0.46) KDM4EHTTALDH1A1L3MBTL1POLB
SCHEMBL17989805 0.83 KDM4E (0.49) KDM4EHTTALDH1A1MAPK1L3MBTL1
SCHEMBL24026132 0.82 KDM4E (0.41) KDM4EHTTMAPTALDH1A1HPGD
SCHEMBL20363738 0.82 MAT2A (0.49) KDM4EL3MBTL1MEN1KMT2AATM

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20210359224-A1 TETRADENTATE PLATINUM AND PALLADIUM COMPLEXES BASED ON BISCARBAZOLE AND ANALOGUES UNIV ARIZONA STATE (US) 2021-11-18 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20210359224-A1 TETRADENTATE PLATINUM AND PALLADIUM COMPLEXES BASED ON BISCARBAZOLE AND ANALOGUES PDCD2L, PDCD1, PDCD4 KDM4E 3798/4885HTT 1580/4885MAPT 425/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.